XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Information
 9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
During the three months ended June 30, 2023, the Company renamed its Industrial segment as "Technologies."
The following table summarizes select operating results for each reportable segment (in millions).
Three Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Revenues
Medical$74.1 $68.8 $214.1 $203.2 
Technologies132.7 122.4 392.4 367.3 
Consolidated revenues$206.8 $191.2 $606.5 $570.5 
Segment Income (Loss) from Operations
Medical$4.0 $4.0 $10.4 $1.6 
Technologies14.7 5.4 45.8 23.7 
Total segment income from operations18.7 9.4 56.2 25.3 
Corporate and other(20.3)(20.5)(60.4)(60.6)
Consolidated loss from operations$(1.6)$(11.1)$(4.2)$(35.3)
The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.
The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).
Revenues
Three Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,Nine Months Ended September 30,
2024202320242023
North America
Medical$67.7 $62.1 $194.3 $185.0 
Technologies70.9 69.8 192.1 189.1 
Total North America138.6 131.9 386.4 374.1 
Europe
Medical6.5 6.7 19.8 18.2 
Technologies58.8 50.7 190.3 167.2 
Total Europe65.3 57.4 210.1 185.4 
Asia Pacific
Medical— — — — 
Technologies2.9 1.9 10.0 11.0 
Total Asia Pacific2.9 1.9 10.0 11.0 
Total revenues$206.8 $191.2 $606.5 $570.5 
The following details revenues by timing of recognition (in millions):
Revenues
Three Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Point in time$149.5 $128.0 $427.0 $371.1 
Over time57.3 63.2 179.5 199.4 
Total revenues$206.8 $191.2 $606.5 $570.5 
The following details revenues by product category (in millions):
Revenues
Three Months Ended September 30,Three Months Ended September 30,Nine Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Medical segment:
Medical$74.1 $68.8 $214.1 $203.2 
Technologies segment:
Reactor Safety and Control Systems54.5 48.7 163.1 141.9 
Radiological Search, Measurement, and Analysis Systems78.2 73.7 229.3 225.4 
Total revenues$206.8 $191.2 $606.5 $570.5